High rates of cognitive impairment persist in human immunodeficiency virus (HIV) infection, despite improved health outcomes and reduced mortality through widespread use of antiretroviral therapy (ART). Heavy alcohol use and cigarette smoking are potential contributors to neurocognitive impairment in people living with HIV (PLWH), yet few studies have examined their influence concurrently. Here we investigated the effects of self-reported alcohol use and smoking on learning, memory, processing speed, verbal fluency, and executive function in 124 HIV-positive men who have sex with men [age (mean ± SD) = 42.8 ± 10.4 years], engaged with medical care. All participants were heavy drinkers. Duration of HIV infection averaged 9.9 ± 7.6 years, and 92.7% were on a stable ART regimen. Participants completed a neuropsychological battery and assessment of past 30-day substance use. Average number of drinks per drinking day (DPDD) was 5.6 ± 3.5, and 33.1% of participants were daily smokers. Rates of neurocognitive impairment were the highest in learning (50.8%), executive function (41.9%), and memory (38.0%). Multiple regression models tested DPDD and smoking status as predictors of neurocognitive performance, controlling for age and premorbid intelligence. Smoking was significantly, negatively related to verbal learning (p = .046) and processing speed (p = .001). DPDD was a significant predictor of learning (p = .047) in a model that accounted for the interaction of DPDD and smoking status. As expected, premorbid intelligence significantly predicted all neurocognitive scores (ps < .01), and older age was associated with slower processing speed (ps < .01). In conclusion, smoking appears to be associated with neurocognitive functioning deficits in PLWH beyond the effects of heavy drinking, aging, and premorbid intelligence. Smoking cessation interventions have the potential to be an important target for improving functional outcomes in heavy drinking PLWH.
Introduction
Antiretroviral therapy (ART) has reduced mortality from human immunodeficiency virus (HIV) infection, yet cognitive impairment continues to affect people living with HIV (PLWH). HIV-associated neurocognitive disorders (HAND) are acquired impairments in cognitive functioning that present along a spectrum of severity and are not attributable to medical or psychiatric comorbidity (Antinori et al., 2007) . In the era of ART, the prevalence of HAND is estimated at 44% in those without severe comorbidities (Heaton et al., 2010) . Although rates of HIV-associated dementia have declined, milder forms of HAND persist despite viral suppression (Heaton et al., 2011) . By definition, the mildest ("asymptomatic") form of HAND entails minimal interference with daily functioning. However, a lack of insight into deficits may lead to a self-report bias in prevalence estimates for more severe forms of HAND (Chiao et al., 2013) . Recent studies have pointed to comorbidities, extent or timeline of viral suppression, and appropriateness of neuropsychological norms as factors that also may influence HAND prevalence estimates (Crum-Cianflone et al., 2013; Cysique & Brew, 2011; Nightingale et al., 2014) .
Heavy alcohol use and smoking frequently co-occur with HIV infection and may compound HAND. Among PLWH, 65% reported alcohol use in the past year, and 15% endorsed binge drinking in the past 30 days (Centers for Disease Control and Prevention, 2014) . HIV infection and alcohol use disorders (AUDs) both are associated with impairment in learning, memory, information processing, and executive functioning (Persidsky et al., 2011) . At 41%, the rate of smoking in PLWH is twice that of the general population, and smoking is a major risk factor for cardiovascular disease, non-AIDS cancer, and opportunistic infection (Centers for Disease Control and Prevention, 2014; Lifson et al., 2010) . In a previous study, we found that smoking also was significantly associated with impaired learning and memory in PLWH (Bryant, Kahler, Devlin, Monti, & Cohen, 2013) . Here we investigated associations of neurocognition with both alcohol use and smoking.
Method

Participants
Participants were 124 men who have sex with men (MSM) living with HIV, recruited from a health center to take part in a clinical trial of a brief intervention for heavy drinking. Baseline, pre-randomization measures are presented here. Inclusion criteria were (1) male;
(2) ≥18 years old; (3) heavy drinking episode (≥5 drinks) at least once per month, or >14 drinks per week; (4) confirmed diagnosis of HIV; and (5) selfreported sex (insertive or receptive, oral or anal) with a male partner in past 12 months. Participants on ART had to be stable on their current regimen for at least three months. Exclusion criteria were (1) current intravenous drug use; (2) current psychosis, suicidality, or mania, determined with the Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Nonpatient Edition (SCID-NP; First, Spitzer, Gibbon, & Williams, 1995) ; (3) treatment within the past three months for an HIV-related opportunistic infection; (4) current treatment for alcohol or drug problem; and (5) score >7 on the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) (Sullivan, Sykora, Schneiderman, Naranjo, & Sellers, 1989) . Participants were asked to abstain from alcohol for 24 hours before assessment, and zero breath alcohol content was confirmed with breath analysis. Participants provided informed consent in a format approved by the relevant Institutional Review Boards. Table 1 presents participant characteristics.
Measures
Self-report measures Alcohol and substance use disorders were assessed using the SCID-NP (First et al., 1995) . The Timeline Followback Interview (Sobell & Sobell, 1992 ) was used to assess standard alcoholic drinks consumed (12 oz. beer, 5 oz. wine, or 1.5 oz. 80-proof liquor) and use of drugs in the past 30 days. Participants were designated daily smokers if they reported smoking ≥20 days. Depressive symptoms were assessed with the Center for Epidemiological Studies-Depression (CES-D) scale (Radloff, 1977) .
Neurocognitive assessment
The battery assessed learning, memory, processing speed, executive function, and verbal fluency. The selected measures (Table 2) are sensitive to deficits associated with HIV and AUDs (Antinori et al., 2007; Cohen et al., 2001 ; Oscar-Berman et al., 2014). Standardized scores were calculated using published norms (Heaton, Miller, Taylor, & Grant, 2004) . Impairment was defined as a score ≥1 standard deviation (SD) below the mean of standardized norms (Carey et al., 2004; Heaton et al., 1995) .
Statistical analysis
Preliminary analyses examined percentages of participants with impairment in each domain. Next, we examined bivariate correlations between drinking variables and raw cognitive scores. We chose drinks per drinking day (DPDD) as the primary alcohol-use variable because research has shown that heavy episodic drinking is detrimental to brain function, overall health, and psychosocial functioning (Crews & Nixon, 2009; Holahan, Schutte, Brennan, Holahan, & Moos, 2014) . The a priori decision to compare daily smokers to a combined group of never, past, and occasional smokers was supported by a preliminary analysis showing no differences in scores among the latter groups and by population-based research (Mons, Schottker, Muller, Kliegel, & Brenner, 2013) . Three sets of multiple linear regression models assessed the effects of selected predictors on cognitive functioning. We used raw scores because adjustments for demographic factors (i.e., age, education, race) were inconsistent across test norms. The preliminary analysis included age, Wechsler Test of Adult Reading (WTAR), education, race, drug use (current/past cannabis dependence, any drug use, or any non-cannabis drug use), and CES-D score as covariates. The final models were chosen through a backward selection procedure in which we removed non-significant covariates one step at a time. Education, race, drug use, and CES-D were non-significant and thus were not retained in subsequent models. The first set of regression models tested associations of DPDD and smoking status with cognitive scores, controlling for age. In the second set of regression models, we tested these associations controlling for age and WTAR. The third set of regression models included an interaction term for smoking and DPDD. Alpha level was set to .05 for statistical significance.
Results
Rates of cognitive impairment
Rates of impairment in learning (50.8%), executive function (41.9%), and memory (38.0%) exceeded the 16% expected on the basis of the normal distribution ( Table 3) .
Contributions of smoking status and alcohol use to cognitive performance
DPDD showed consistent associations with neurocognitive scores in bivariate correlations (Table 4 ). The first set of regression models (Table 5) , controlling for age, showed a significant, negative association of current smoking with learning, memory, and processing speed. Age was a significant predictor of processing speed. Premorbid functioning was a significant predictor of all domains across models.
In the second set of regression models, controlling for age and premorbid intelligence, smoking status was a significant predictor of learning and processing speed. Age remained a significant predictor of processing speed.
In the third set of models, which included the interaction of DPDD and smoking status, the interaction term was a significant predictor of learning, as were DPDD and smoking status individually. The direction for the interaction effect was opposite to individual effects for DPDD and smoking status. The post hoc follow-up analysis showed that the slope for DPDD on learning was negative for non-daily smokers (B = −.06, p = .610) but positive for daily smokers (B = .22, p = .114).
Finally, the possibility that neurocognitive deficits associated with smoking might be related to lifetime substance exposure was explored in a post hoc chisquare test on binary (yes/no) variables for current smoking and lifetime substance-use disorder. Current smokers were significantly more likely to report lifetime substance use disorders than non-smokers, χ 2 (1) = 9.59, p = .002.
Discussion
In this study, we found elevated rates of impairment in learning, executive function, and memory in heavy drinking, HIV-positive MSM, consistent with previous studies on HIV infection and alcohol use (Persidsky et al., 2011) . The main findings further our understanding of neurocognition in PLWH. First, daily smoking was significantly associated with decrements in verbal learning and processing speed, and these associations persisted after controlling for premorbid intelligence, age, and alcohol use. This finding replicates and extends key aspects of our earlier study showing that smoking predicted poorer learning, memory, and global cognition in an independent sample of PLWH (Bryant et al., 2013) . Regarding clinical and functional implications, previous research identified the measure of processing speed associated with smoking status, the Digit Symbol test, as a strong independent predictor of quality of life in PLWH (Tozzi et al., 2003) . Second, premorbid intelligence significantly predicted performance in all domains, and age significantly predicted processing speed. These results underscore the importance of using demographically appropriate norms and comparing an individual's current functioning to his or her own baseline where possible. Third, DPDD showed correlations with memory, processing speed, and verbal fluency, but associations were not significant in adjusted models. A significant negative effect of DPDD on learning emerged when including the interaction of DPDD and smoking. However, the interaction effect, in which DPDD had a positive slope on learning for daily smokers and negative slope for non-daily smokers, is difficult to interpret and underscores the non-causal nature of findings in this observational study.
Generalizability is limited by the all-male sample and high average educational attainment. An important future direction is to compare HIV-positive and HIVnegative groups of MSM to quantify the direct influence of HIV infection on neurocognition after accounting for methodological, demographic, and behavioral factors.
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